×

Tag: Longevity Market Recap

Longevity Desci Recap July 2024
The Longevity and DeSci Recap is back, and our latest edition covers high-profile events including the Longevity Investors Conference in Gstaad, new innovations in AFib monitoring, and even some celebrity-related news. This month, we’ll continue to explore the latest events, current research, and investment news to give you a complete round-up of the current landscape...
Longevity Desci Recap June 2024
This summer season is red hot in the world of longevity. Packed with interesting events, investments and new research proposals, the future of longevity is becoming today’s reality. Join us as we run through the happenings of June 2024 and what’s been going on in the longevity and DeSci world. Upcoming conferences and events On...
Longevity Desci Recap May 2024
In this latest edition of the Longevity and DeSci Recap, we’ll take a look back at May’s events, research, and investments to give you the latest update on what’s going on in the Longevity and DeSci world. As the weather is heating up, so too are events surrounding longevity. Not only are there four great...
Longevity Desci Recap April 2024
In this latest edition of the Longevity and DeSci Recap, we’ll be taking a look back over a month full of events, research, and investments. As we head into spring, renewed life is on the horizon with continued investments in the longevity sector and the announcement of a permanent longevity/DeSci hub being launched on the...
Desci March
Welcome back for the latest edition of the Longevity and DeSci Recap. This March has seen a swarm of activity as the longevity and DeSci world has sprung to renewed life. Between the many upcoming conferences, latest investment news, and innovations happening at the Vitalia pop-up city in Honduras, the longevity world could be set...
Longevity DeSci Feb 2024
Last month has been a hive of activity in the longevity finance sphere, with a number of significant fundings taking place that are set to generate new lifespan solutions for the future. Highlights include Yuva Biosciences' $7.5 million for anti-hair loss tech, Tagomics' £6.7 million for cutting-edge disease diagnostics, and GlycanAge’s $4.2 million to fine-tune...